Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune disease

16 Apr 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction
Share to Monoclonal and Polyclonal Antibodies Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29673902
DOI: 10.1016/j.clim.2018.04.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune diseasePMID 29673902Read ↗

Chimeric antigen receptor T cell therapy for autoimmune diseaseSemantic proximity Read ↗

B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: Tools to study the regulation of the autoimmune responseSemantic proximity Read ↗

Antigen-specific nanomedicines for the treatment of autoimmune disease: target cell types, mechanisms and outcomesSemantic proximity Read ↗

Autoimmune disease is the next frontier for CAR T cell therapySemantic proximity Read ↗

NK Cells in Autoimmune Diseases: Protective or Pathogenic?Semantic proximity Read ↗

CAR-T AND autoimmune diseases in nervous systemSemantic proximity Read ↗

Universal protection of allogeneic cell therapies from natural killer cells via CD300a agonismSemantic proximity Read ↗

The NK-92 cell line—30 years later: its impact on natural killer cell research and treatment of cancerSemantic proximity Read ↗

A new therapeutic pathway in autoimmune diseases: chimeric antigen receptor T cells (CAR-T) targeting specific cell subtypes or antigen-specific B lymphocytes—a brief reviewSemantic proximity Read ↗

Off-the-shelf CAR-T cells could prove paradigm shifting for autoimmune diseasesSemantic proximity Read ↗

T cells as therapeutic targets in SLESemantic proximity Read ↗

Beyond pan-B-cell-directed therapy — new avenues and insights into the pathogenesis of SLESemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.